Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05803421 |
|---|---|
| Brief Title: | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4) |
| First Submitted : | March 27, 2023 |
| First Submitted that Met QC Criteria : | March 27, 2023 |
| First Posted : | April 7, 2023 |
| Last Update Submitted that Met QC Criteria : | March 12, 2024 |
| Last Update Posted : | March 13, 2024 |